Retraction Note: MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1
L.-H. Xia, Q.-H. Yan, Q.-D. Sun, Y.-P. Gao Endoscopy Center, Linyi Central Hospital, Linyi, China
The article “MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1” by L.-H. Xia, Q.-H. Yan, Q.-D. Sun, Y.-P. Gao published in Eur Rev Med Pharmacol Sci 2018; 22 (17): 5546-5553–DOI: 10.26355/eurrev_201809_15816–PMID: 30229827 has been retracted in accordance with the Publisher and the Editor in Chief.
Following some concerns raised on PubPeer, the Journal has started an investigation to assess the validity of the results as well as possible figure manipulation.
The journal’s investigation confirmed several instances of Figure duplication with previously published articles, specifically in Figures 3 and 4.
The authors were contacted, informed of the ongoing investigation, and requested to provide the original data supporting the manuscript, but they remained unresponsive.
As a result, the Journal has decided to retract this article.
This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadMiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
L.-H. Xia, Q.-H. Yan, Q.-D. Sun, Y.-P. Gao
Retraction Note: MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1
Eur Rev Med Pharmacol Sci
Year: 2025
Vol. 29 - N. 11
Pages: 490-490
DOI: 10.26355/eurrev_202511_37517
Publication History
Published online: 28 Nov 2025